Patents by Inventor Ciaran HARTE

Ciaran HARTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine adjuvants
    Patent number: 12629415
    Abstract: The present application relates to an adjuvant which is suitable to be used in vaccines or other immunogenic compositions. Specifically, the adjuvant promotes the induction of interleukin-1 (IL-1), type 1 interferons (IFNs), such as IFN?, and IFN?, type 2 interferons, such as IFN? and/or tumour necrosis factor (TNF) response, such as TNF?, and elicits or enhances an immune response, preferably in neonatal, juvenile or paediatric animal and/or human populations.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: May 19, 2026
    Assignees: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN, TEAGASC, THE AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY
    Inventors: Edward Lavelle, Sarah Doyle, Ciaran Harte, Kiva Brennan, Kieran Meade
  • VACCINE ADJUVANTS
    Publication number: 20210187104
    Abstract: The present application relates to an adjuvant which is suitable to be used in vaccines or other immunogenic compositions. Specifically, the adjuvant promotes the induction of interleukin-1 (IL-1), type 1 interferons (IFNs), such as IFN?, and IFN?, type 2 interferons, such as IFN? and/or tumour necrosis factor (TNF) response, such as TNF?, and elicits or enhances an immune response, preferably in neonatal, juvenile or paediatric animal and/or human populations.
    Type: Application
    Filed: May 29, 2019
    Publication date: June 24, 2021
    Inventors: Edward LAVELLE, Sarah DOYLE, Ciaran HARTE, Kiva BRENNAN, Kieran MEADE